2 out of 3 Dabur entities get relief in US cancer lawsuits – what is the case all about?

livemint.com:

Dabur entities, that were listed as defendants in multiple lawsuits in the United States alleging their products caused cancer, have found relief from the court. The India-headquartered FMCG major, in a statement, noted that Dabur International and Dermoviva Skin Essentials – two of its subsidiaries – have been removed as defendants in the lawsuits filed before the the US District Court for the Northern District of Illinois.

However, lawsuits filed against its third international subsidiary Namaste Laboratories LLC, would continue before the US court, the company noted. Also Read: Mahadev Betting App Scam: Dabur chairman-director duo listed in FIR against illegal syndicate "We wish to inform that Dabur and Dermoviva have been dismissed as defendants in federal cases, which were consolidated as a Multi-District Litigation, before the US District Court for the Northern District of Illinois, for lack of personal jurisdiction as neither Dabur nor Dermoviva manufactured, marketed, distributed or sold hair relaxer products in the US," the statement noted.

Three foreign subsidiaries of Dabur India -- Namaste Laboratories LLC, Dermoviva Skin Essentials Inc and Dabur International Ltd -- were facing approximately 5,400 cases in the federal and state courts in the US, which was later consolidated to the Northern District of Illinois, the company had last month disclosed in a regulatory filing. The companies were facing allegations that their hair-relaxer products caused ovarian cancer, uterine cancer and other related health issues.